Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 50.13 as of 2026-10-06T22:42:55.065Z.
Consensus retrieved: 2026-10-06T15:30:37.666Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T22:42:55.065Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c423fd58fa010454b187d960c45a161fd4b2d9bd49eac7b4b936e7343169081d
Forward PE Ratio (50.13) = Dated Quote Price ($63.70) / Consensus Forward EPS ($1.27)
FORWARD PE RATIO
50.13
SECTOR MEDIAN · HEALTHCARE
19.79
median of 190 covered companies
CURRENT VS SECTOR MEDIAN
+153.37%
vs the sector median at left
PTC Therapeutics, Inc.
Market Cap
$5.32B
Forward PE Ratio
50.13
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | $5.32B | 50.13 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | N/A |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | N/A |
| Sotera Health Company (SHC)vs › | $5.20B | 18.53 |
| Doximity, Inc. (DOCS)vs › | $5.20B | 20.63 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 29.17 |
| RadNet, Inc. (RDNT)vs › | $5.53B | 136.65 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 19.75 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
50.1
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $63.70, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.27 | $0.55 – $1.95 | 7 | 50.1x |
| 2027-12-31 | $2.68 | $1.24 – $4.63 | 7 | 23.7x |
| 2028-12-31 | $4.87 | $1.71 – $7.01 | 10 | 13.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
